BIO's Greenwood On India, Bayer's China Strategy, And Pfizer's Lipitor Battle In The Philippines - Latest From PharmAsia News

BIO President Jim Greenwood Says Indian Biosimilars Welcome In U.S. Market: An Interview With PharmAsia News (Part 1 of 2)

11/30/09 8:23 GMT

Primary Care Focus Is Key To Bayer's Leading Position In China

11/30/09 8:00 GMT

China Releases New Guidelines For Drug And Device Price Reforms

11/30/09 7:46 GMT

Pfizer, Unilab Prepare For Battle Over Lipitor Patent In The Philippines

11/30/09 7:37 GMT

 

Not a subscriber to PharmAsia News? To register for a free trial, click here.